3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential

Yassir Younis, Frederic Douelle, Tzu-Shean Feng, Diego Gonzalez Cabrera, Claire Le Manach, Aloysius T Nchinda, Sandra Duffy, Karen Louise White, David Shackleford, Julia Morizzi, Janne Martti Mannila, Kasiram Katneni, Ravi Bhamidipati, Mohammed K Zabiulla, Jayan T Joseph, Sridevi Bashyam, David Waterson, Michael J Witty, David Hardick, Sergio WittlinVicky M Avery, Susan Ann Charman, Kelly Chibale

Research output: Contribution to journalArticleResearchpeer-review

101 Citations (Scopus)


Malaria is a disease that is prevalent in many developing countries. According to the World Health Organization 2011 report, malaria is responsible for 216 million clinical cases and 655000 deaths in 2010, especially among children and pregnant women.1 Malaria is caused by protozoan parasites of the genus Plasmodium that infect and destroy red blood cells, leading to fever, severe anemia, cerebral malaria, and, if untreated, death. Plasmodium falciparum is the dominant species in sub-Saharan Africa and is responsible for the most deaths. The disease burden is heaviest in African children under 5 years of age. Plasmodium vivax causes 25-40 of the global malaria burden, particularly in South and Southeast Asia and Central and South America. The other two main species that are known to infect humans are Plasmodium ovale and Plasmodium malariae.
Original languageEnglish
Pages (from-to)3479 - 3487
Number of pages9
JournalJournal of Medicinal Chemistry
Issue number7
Publication statusPublished - 2012

Cite this